Balance Sheet Data
Vanda Pharmaceuticals Inc. (VNDA)
$3.9
+0.18 (+4.84%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 257.36 | 312.13 | 367.74 | 432.81 | 466.86 | 417.37 | 448.49 | 481.92 | 517.85 | 556.46 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 28.78 | 26.37 | 30.04 | 32.47 | 33.51 | 34.92 | 37.52 | 40.32 | 43.32 | 46.55 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.99 | 1.14 | 1.28 | 1.03 | 1.19 | 1.30 | 1.40 | 1.50 | 1.62 | 1.74 |
| Inventories (%) | ||||||||||
| Accounts Payable | - | - | - | 0.92 | 12.69 | 7.29 | 7.83 | 8.42 | 9.04 | 9.72 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -25.37 | -1.02 | -1.79 | -0.55 | -0.68 | -8.08 | -8.68 | -9.33 | -10.03 | -10.77 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.